Prolonged deficiency of protein C following hematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 17, Issue 3, 1996, Pages 415-419

  Gordon, B ^a   Haire, W ^a   Ruby, E ^b   Stephens, L ^a   Kotulak, G ^a   Kessinger, A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Hematopoietic growth factors; Hypercoagulable state; Protein C

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYUREA; PROTEIN C; THIOTEPA;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER; CANCER CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; HEMATOPOIETIC STEM CELL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; RISK FACTOR; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

ADULT; AGED; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MIDDLE AGED; PROTEIN C DEFICIENCY; RISK FACTORS; TIME FACTORS;

EID: 0029865507     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Broekmans AW, Veltkamp JJ, Bertina RM. Congenital protein C deficiency and venous thromboembolism: a study of three Dutch families. New Engl J Med 1983; 309: 340-344.
2. Griffin JH, Evart B, Zimmerman TS et al. Deficiency in protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373.
3. Dusser A, Boyer-Neumann C, Wolf M. Temporary protein C deficiency associated with cerebral arterial thrombosis in childhood. J Pediatr 1988; 113: 849-851.
4. Gordon BG, Saving KL, McCallister JA et al. Cerebral infarction associated with protein C deficiency following allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 8: 323-325.
5. Gordon BG, Haire WD, Kessinger A et al. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma. Bone Marrow Transplant 1991; 8: 497-502.
6. Harper PL, Jarvis J, Jennings I et al. Changes in the natural anticoagulants following bone marrow transplantation. Bone Marrow Transplant 1990; 5: 39-42.
7. Haire WD, Lieberman RP, Edney JA et al. Hickman catheter induced thoracic vein thrombosis: frequency and long term sequelae in patients receiving high dose chemotherapy and marrow transplantation. Cancer 1990; 66: 900-908.
8. Shulman HM, Gown AM, Nugent DL. Hepatic veno-occlusive disease after bone marrow transplantation: immunohistochemical identification of the material within occluded central venules. Am J Pathol 1987; 127: 549-558.
9. Lopez JA, Ross RS, Fishbein MC, Siegel RJ. Nonbacterial thrombotic endocarditis: a review. Am Heart J 1987; 113: 773-784.
10. Gordon BG, Haire WD, Patton DF et al. Thrombotic complications of bone marrow transplantation (BMT): association with protein C deficiency. Bone Marrow Transplant 1993; 11: 61-65.
11. Haire WD, Ruby EI, Gordon BG et al. Antithrombin III (ATIII) and protein C (PC) deficiencies during hematopoietic stem cell transplantation (HSCT) correlate with organ dysfunction and death. Blood 1993; 82: 406a (abstr.).
12. Gordon BG, Haire WD, Ruby EI. Protein C (PC) and antithrombin III (ATIII) deficiency in children undergoing autologous bone marrow transplantation (ABMT). Blood 1993; 82: 617a (abstr.).
13. Young GA, Hill GL. Assessment of protein-calorie malnutrition in surgical patients from plasma proteins and anthropometric measurements. Am J Clin Nutr 1978; 31: 429-435.
14. Kaufman PA, Jones RB, Greenberg CS, Peters WP. Autologous bone marrow transplantation and factor XII. factor VII and protein C deficiencies. Report of a new association and its possible relationship to endothelial cell injury. Cancer 1990; 66: 515-521.
15. Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood 1987; 70: 343-350.
16. Faioni EM, Krachmalnicoff A, Bearman SI et al. Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver. Blood 1993; 81: 3458-3462.
17. Harper JL, Haire WD, Ruby EI et al. Prehematopoietic stem cell transplant levels of protein C and antithrombin III have no predictive value for posttransplant organ dysfunction. Blood 1993; 82: 618a (abstr.).
18. Goodnough LT, Saito H, Manni A et al. Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 15 patients. Cancer 1984; 54: 1264-1268.
19. Levine MN, Gent M, Hirsh J et al. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. New Engl J Med 1988; 318: 404-407.
20. Haire WD, Gordon BG, Stephens LC et al. Granulocyte/monocyte colony stimulating factor: association with antithrombin III and protein C deficiencies after peripheral blood stem cell transplantation. Clin Res 1994; 42: 136a (abstr.).